
APEX Calendar: Release Schedule, Listings, Hard Fork, Halving
USDT Perpetual Contracts on ApeX Pro Discontinuation
ApeX Token has announced the discontinuation of USDT perpetual contracts on its ApeX Pro platform, effective December 6th at 5:00 am UTC.
Omni Zealy Sprint
ApeX Token has announced that the ApeX Omni Zealy Sprint will start on December 2nd.
Buy-Back and Share (BBS) Program
ApeX Token has announced the start of its APEX token buy-back as part of the upcoming Buy-Back and Share (BBS) Program, scheduled to launch in November.
Tokens Unlock
ApeX Token will unlock 9,240,000 APEX tokens on November 27th, constituting approximately 19.09% of the currently circulating supply.
Shutdown of ApeX Pro USDT Markets
ApeX Protocol has successfully migrated its USDT markets to the new platform ApeX Omni and will officially shut down the ApeX Pro platform on October 30, 2024, at 10:00 AM UTC.
Crypto Fight Week in London
ApeX Token is set to participate in the upcoming Crypto Fight Week event in London on June 15th.
TOKEN2049 in Dubai
ApeX Token is set to participate in the TOKEN2049 conference in Dubai on APril 18th-19th.
Bot Upgrade
ApeX Token has announced an upgrade to the ApeX bot on March 13th. The upgrade is designed to enhance the trading experience on ApeX via Telegram Messenger.
AMA on Discord
ApeX Token will host an AMA on Discord on February 19th at 2 pm UTC. During the livestream, participants will have the opportunity to share their trade ideas.
Partnership With Camelot
ApeX Token has formed a partnership with Camelot. This collaboration is expected to open up new opportunities for passive income for the ApeX Token community.
Token Burn
ApeX Token will burn 15% of the total ApeX Token supply on January 18th.
Listing on
MEXC
MEXC will list ApeX Token (APEX) on the 10th of January at 10:00 UTC. The trading pair to be listed is APEX/USDT.
ApeX Bot Launch
ApeX Token is launching a new product, the ApeX Bot. This bot is a self-custodial and decentralized perp trading bot that operates via the Telegram messenger.